![]() |
市场调查报告书
商品编码
1773422
医疗科技塑胶注塑机市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测Plastic Injection Molding Machine for MedTech Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球医疗技术市场塑胶注塑机的价值为 21.8 亿美元,预计到 2034 年将以 4.6% 的复合年增长率增长至 34 亿美元。人口老化和美国和欧洲慢性病激增推动了这一需求,导致对高品质、可靠医疗设备的需求增加。这些设备通常需要专为长期照护和慢性病管理设计的复杂包装组件。新兴市场医疗保健产业的扩张为美国和欧洲的机器製造商带来了诱人的成长前景,无论是透过出口还是透过为满足这些地区需求的国内医疗技术原始设备製造商提供服务。此外,亚太、拉丁美洲、东欧和中东部分地区等地区不断增长的医疗保健支出,也提高了对经济高效且精确的医疗设备生产的需求。
製造业在岸化趋势和合约製造网路的快速扩张正在积极重塑全球医疗科技生产格局,为塑胶射出成型机供应商创造新的发展动力。随着製造商寻求减少对海外供应链的依赖,并降低地缘政治和物流风险,许多製造商正在将生产迁移到更靠近北美和欧洲等关键市场的地方。这种转变推动了对高度自动化、高精度注塑机的需求,这些注塑机支援精益生产模式并符合无尘室标准。此外,合约製造合作伙伴正在扩大生产规模,以处理医疗科技原始设备製造商 (OEM) 的多样化产品组合,这推动了对能够高效、大批量生产复杂部件的多功能注塑机的需求。这些不断发展的动态正在为专注于医疗级应用的机器製造商开闢长期成长途径。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 21.8亿美元 |
预测值 | 34亿美元 |
复合年增长率 | 4.6% |
2024年,液压领域产值达到8.916亿美元,预计2034年将以3.9%的复合年增长率成长。儘管液压系统能耗高,但其高注射压力、卓越的锁模力和耐用性使其非常适合复杂生物医学零件的大量生产。它们在高温下成型高黏度材料时表现出色,使其成为关键医疗零件生产的可靠选择。
2024年,0-200吨锁模力的射出成型机占据了59.3%的市场份额,预计到2034年将以5.1%的复合年增长率成长。这些紧凑型系统能够在洁净室内精确成型小型一次性零件,例如手术和牙科器械。其节能、更短的成型週期以及大批量生产精密零件的能力使其成为医疗科技领域不可或缺的一部分。
美国医疗科技市场塑胶射出成型机在2024年创下了5.189亿美元的产值,预计到2034年将以3.1%的复合年增长率成长。由于液压注塑机成本效益高,且能够生产大量、复杂的零件,尤其是在合约製造领域,因此国内市场对液压注塑机的偏好强烈。电动注塑机也因其快速循环、低噪音和低维护成本的特点,在中小企业和研究实验室中越来越受到青睐。美国医疗科技公司越来越重视能源效率、清洁操作和精度,从而推动液压和电动平台之间的市场平衡。
全球医疗科技市场塑胶射出成型机的领导製造商包括美联(Million)、JSW、住友德马格(Sumitomo Demag)、日精塑胶工业株式会社(Nissei Plastic Industrial Co., Ltd.)、泰瑞机械(Tederic Machinery)、威猛巴顿菲尔(Wittmann Bats, Ltd.)、泰瑞机械(Tederic Machinery)、威猛巴顿菲尔(Wittmann Battenfeld)、阿博克龙Milacron)、博乐机械(Bohle Machinery)、内格里博西(Negri Bossi)、震雄集团(Chen Hsong Holdings Limited)、恩格尔(Engel)、巴顿菲尔(Battenfeld)和赫斯基注塑系统(Husky Injection Molding Systems)。在这个专业设备市场中营运的公司正在采取策略性措施来巩固其竞争地位。他们专注于开发专为医疗级零件设计的精密工程机器,同时投资研发以提高能源效率和循环速度。
与医疗科技原始设备製造商 (OEM) 的合作有助于验证机器在高要求应用中的效能,而全球服务网路则可确保快速的支援和维护。此外,製造商正在客製化产品以符合区域洁净室标准和监管需求,并透过预测性维护和远端监控等智慧製造功能增强数位化能力。
The Global Plastic Injection Molding Machine for MedTech Market was valued at USD 2.18 billion in 2024 and is estimated to grow at a CAGR of 4.6% to reach USD 3.4 billion by 2034. Demand is being driven by aging demographics and a surge in chronic diseases across the U.S. and Europe, resulting in increased requirements for high-quality, reliable medical devices. These devices often require intricate packaging components designed for long-term care and chronic disease management. Expansion in emerging market healthcare sectors presents compelling growth prospects for U.S. and European machine manufacturers, both through exports and through servicing domestic MedTech OEMs catering to these geographies. Additionally, rising healthcare expenditures in regions like Asia-Pacific, Latin America, Eastern Europe, and parts of the Middle East are elevating demand for cost-effective yet precise medical device production.
A broader trend toward onshoring and the rapid expansion of contract manufacturing networks is actively reshaping the global MedTech production landscape, creating new momentum for plastic injection molding machine suppliers. As manufacturers seek to reduce reliance on overseas supply chains and mitigate geopolitical and logistical risks, many are relocating production closer to key markets such as North America and Europe. This shift is fueling demand for highly automated, precision-focused molding machines that support lean manufacturing models and cleanroom compliance. Additionally, contract manufacturing partners are scaling up facilities to handle diverse product portfolios for MedTech OEMs, driving the need for versatile molding platforms capable of producing intricate components efficiently and at high volumes. These evolving dynamics are opening long-term growth avenues for machine makers specializing in medical-grade applications.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $2.18 Billion |
Forecast Value | $3.4 Billion |
CAGR | 4.6% |
The hydraulic segment generated USD 891.6 million in 2024 and is projected to grow at a CAGR of 3.9% through 2034. Though energy-intensive, their high injection pressures, exceptional clamping force, and durability suit large-batch production of complex biomedical components. Their consistent performance in molding high-viscosity materials under high temperatures makes them a dependable choice for critical medical parts production.
Machines with 0-200-ton clamping force segment held a 59.3% share in 2024 and are forecast to grow at a CAGR of 5.1% through 2034. These compact systems enable precise molding of small, disposable components-such as surgical and dental devices-within cleanroom settings. Their energy efficiency, shorter cycle times, and ability to produce high volumes of precision parts make them indispensable for the MedTech sector.
U.S. Plastic Injection Molding Machine for MedTech Market generated USD 518.9 million in 2024 and is expected to grow at a 3.1% CAGR through 2034. Domestic preference for hydraulic machines is strong due to their cost-effectiveness and capability for large-shot, complex part production, especially in contract manufacturing. Electric machines are also gaining traction in SMEs and research labs for their fast cycles, low noise, and minimal upkeep. U.S. MedTech firms increasingly value energy efficiency, clean operation, and precision, driving a balanced market between hydraulic and electric platforms.
Leading manufacturers in the Global Plastic Injection Molding Machine for MedTech Market include Million, JSW, Sumitomo Demag, Nissei Plastic Industrial Co., Ltd., Tederic Machinery, Wittmann Battenfeld, Arburg, Netstal, Ferromatik Milacron, Bohle Machinery, Negri Bossi, Chen Hsong Holdings Limited, Engel, Battenfeld, and Husky Injection Molding Systems. Companies operating in this specialized equipment market are employing strategic initiatives to reinforce their competitive positions. They focus on developing precision-engineered machines designed for medical-grade components while investing in R&D to improve energy efficiency and cycle speed.
Collaborations with MedTech OEMs help validate machine performance for demanding applications, while global service networks ensure rapid support and maintenance. Furthermore, manufacturers are customizing products to match regional cleanroom standards and regulatory needs and are enhancing digital capabilities through smart manufacturing features like predictive maintenance and remote monitoring.